Dosing & Uses
Fungal Infections
Pending FDA approval for treatment of invasive fungal infections in patients who have limited or no treatment options, including aspergilllosis, lomentosporiosis, scedosporiosis, Scopulariopsis infections, and refractory extrapulmonary coccidioidomycosis, or probable pulmonary invasive aspergillosis
Next:
Pharmacology
Mechanism of Action
Selectively inhibits fungal dihydroorotate dehydrogenase (DHODH), a key enzyme in fungal pyrimidine biosynthesis
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
